Project Number 5R01AG034155-02 Agency/Funding Organization NIA Funding Year 2010 View Full Project Details for STUDY ON THALIDOMIDE AS BACE1 INHIBITOR IN ALZHIEMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) a. Amyloid beta Researcher and Organization Principal Investigator SABBAGH, MARWAN N Principal Investigator First Name MARWAN N Principal Investigator Last Name SABBAGH Awardee Organization BANNER SUN HEALTH RESEARCH INSTITUTE Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-08-062: Alzheimers Disease Pilot Clinical Trials (R01) FY Overall Cost $839,712 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Repository [AlzPED] Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of beta-Secretase in a Mouse Model of Alzheimer’s Disease Clinical Trial Thalidomide for Patients With Mild to Moderate Alzheimer's Disease
